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ABSTRACT
Five organogermanium compounds with the formulae Ph3GeCHR’ CH.CONHNHC(X)NHR" and
N--NH
Ph3GeCHR’ CH.C C X
N
a t!
( R’ H, Ph; R" Ph, p-CH3-Ph X S, O) were found to possess inhibitory effects on gastric
carcinoma MGC-803 in vitro.
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It has been reported that trialkylgermylpropanoic acids and their derivatives showed antibacterial
activity
[1 and the selectively inhibitory action on the decomposition of enzymes[2. However, no
antitumor properties of these compounds have been known in the literature. In our previous work;,
we have reported the syntheses of some 1-triphenylgermyl-4-propiono-substituted semicarbazides,
thiosemicarbazides (1) and their heterocyclic derivatives (2). In the present paper, we report the
antitumor activity of these compounds.
Table
Compounds
Effects of 1 and 2 on gastric carcinoma MGC-803
Inhibition rate (
lppm lOppm lOOppm
la 38.4 32.8 18.4
lb 20.0 28.8 60.8
lc 8.0 21.6 28.0
2a 28.0 40.0 48.0
2b O. O0 4.80 15.2
Inhibition rate reported in this paper was tested according to reference 4.
Dimethyl sulfoxide was used as solvent, the same in Tables 2 and 3.
Table 2 Effects of 1 and 2 on gastric carcinoma BGC-823
Compounds Inhibition rate (o )
lppm lOppm lOOppm
la -6.82 -12.5 -1.55
lb -4.55 -2.27 68.18
lc -14.77 -9.09 19.32
2a -9.09 -4.45 9.09
2b -34.15 -15.85 -6.10
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Table 3 Effects of 1 and 2 on nasopharyneal darcinoma KB
Compounds Inhibition rate (%
lppm lOppm lOOppm
la -11.63 -8.53 -3.10
lb -7.75 20.93 56.59
lc -1.55 4.65 25.58
2a -13.18 7.75 18.60
2b -6.20 -9.30 -3.80
Ph3GeCHR’ CHzC(O)NHNHC(X)NHR"
N--NH







R’ --H,X--S ,R" p-CH-Ph




R --H ,X--S ,R" =p-CH-Ph
R’ --Ph,X--O ,R" =Ph
As shown in Table 1, to some extent, compounds 1 and 2 are all effective against gastric
carcinoma MGC-803 under the experimental conditions. However, no inhibitory effects were found
against gastric carcinoma BGC-823 or nasopharyneal darcinoma KB under the same conditions as
above (see Tables 2 and 3).
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